Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Clinical trial NCT06760637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06760637
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-06
- Primary completion
- 2029-01-02
- Enrollment
- 1035
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.